Angiodynamics (ANGO) Share-based Compensation (2010 - 2026)

Angiodynamics' Share-based Compensation history runs 17 years deep, the most recent figure standing at $3.9 million for Q2 2026.

• Quarterly Share-based Compensation rose 138.57% year-over-year to $3.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $14.0 million (up 42.86% YoY) and the FY2026 annual result came in at $14.0 million, up 42.86% from the prior year.
• Share-based Compensation was $3.9 million for Q2 2026 at Angiodynamics, up from $2.7 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $4.5 million in Q3 2025 and bottomed at $1.6 million in Q2 2025.
• A 5-year average of $2.8 million and a median of $2.8 million in 2025 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2023 — Share-based Compensation slumped 43.97% — and 2026, when it soared 138.57%.
• Angiodynamics' Share-based Compensation stood at $3.4 million in 2022, then tumbled by 43.97% to $1.9 million in 2023, then jumped by 34.68% to $2.5 million in 2024, then climbed by 14.36% to $2.9 million in 2025, then jumped by 35.42% to $3.9 million in 2026.
• Business Quant data shows ANGO's Share-based Compensation at $3.9 million in Q2 2026, $2.7 million in Q1 2026, and $2.9 million in Q4 2025.